Guardant Health (GH) Receivables (2017 - 2026)

Guardant Health has disclosed Receivables across 10 years of filings, most recently posting $143.6 million for Q1 2026.

• Receivables for Q1 2026 came in at $143.6 million, up 20.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $143.6 million (up 20.04% YoY), and the FY2025 annual result was $143.0 million, up 25.86% from the prior year.
• Receivables came in at $143.6 million for Q1 2026 at Guardant Health, roughly flat from $143.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $143.6 million in Q1 2026 to a low of $87.4 million in Q1 2022.
• The 5-year median for Receivables is $100.2 million (2022), against an average of $106.7 million.
• Across the five-year window, Receivables fell 9.29% in 2023 and soared 34.62% in 2025, its largest moves.
• Guardant Health's Receivables stood at $102.7 million in 2022, then retreated by 8.74% to $93.7 million in 2023, then rose by 21.32% to $113.7 million in 2024, then gained by 25.86% to $143.0 million in 2025, then rose by 0.39% to $143.6 million in 2026.
• The last three Receivables figures came in at $143.6 million (Q1 2026), $143.0 million (Q4 2025), and $120.7 million (Q3 2025), per Business Quant data.